In our study, using the holistic immune repertoire technology, we found reduced uCDR3 numbers, reduced repertoire diversity in all seven TCR/BCR chains and skewed TRB and IgH V/J usage in convalescent COVID‐19 patients. This evidence concerns the gene BCR and COVID-19.